DeGeeter Michelle, Taylor Shawn Riser, Okarlton Ece Ilkiz, Ellex Jamie, Dolder Christian
Wingate University, Hendersonville, NC, USA.
VA Northern California Healthcare System, El Dorado Hills, CA, USA.
J Pharm Technol. 2018 Oct;34(5):194-198. doi: 10.1177/8755122518779338. Epub 2018 Jun 5.
Obesity is linked to many accompanying comorbidities and has a substantial effect on the cost of health care. Pharmacist are able to provide management and intervention for the treatment of these disease states. This study examined outcomes 12 months prior to pharmacist intervention and 6 months postintervention. The primary outcome was to determine if pharmacist service intervention resulted in improved markers of weight and diabetes. This study revealed significant improvement in the HgbA1c and body mass index (BMI) from baseline (A1c 7.9%, BMI 35.3 kg/m) to postintervention (A1c 7%, BMI 34.1 kg/m). These results were statistically significant ( < .001, Bonferroni correction applied for multiple comparisons), indicating the clinical importance of adding pharmacists to the health care team in obesity and diabetes management.
肥胖与许多伴随的合并症相关，并且对医疗保健成本有重大影响。药剂师能够为这些疾病状态的治疗提供管理和干预。本研究考察了药剂师干预前12个月和干预后6个月的结果。主要结果是确定药剂师服务干预是否能改善体重和糖尿病指标。本研究显示，糖化血红蛋白（HgbA1c）和体重指数（BMI）从基线水平（糖化血红蛋白7.9%，体重指数35.3kg/m²）到干预后（糖化血红蛋白7%，体重指数34.1kg/m²）有显著改善。这些结果具有统计学意义（P<0.001，采用Bonferroni校正进行多重比较），表明在肥胖和糖尿病管理中，将药剂师纳入医疗团队具有临床重要性。
